OverviewSuggest Edit
Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. The Company's product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Designed around key issues with challenging anatomies, difficult access, and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes.
| Type | Public | |
| Founded | 1992 | |
| HQ | Irvine, CA, US | Map |
| Website | endologix.com | |
| Employee Ratings | More |
Key People/Management at Endologix
John Onopchenko
Cindy Pinto
Reyna Fernandez
Jeff Brown
Michael Chobotov
Jeffry Fecho
Endologix Office Locations
Endologix Financials and Metrics
Endologix Revenue
| USD | |
|---|---|
Revenue (Q2, 2020) | 24.8m |
Gross profit (Q2, 2020) | 14.2m |
Gross profit margin (Q2, 2020), % | 57% |
Net income (Q2, 2020) | (26.1m) |
EBIT (Q2, 2020) | (17.3m) |
Market capitalization (1-Oct-2020) | 4.2m |
Closing stock price (1-Oct-2020) | 0.0 |
Cash (30-Jun-2020) | 18.5m |
EV | 382.2m |
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 42.6m | 48.6m | 46.0m | 42.3m | 44.7m | 34.8m | 35.6m | 36.2m | 35.8m | 28.5m | 24.8m |
Cost of goods sold | 14.0m | 16.3m | 16.9m | 14.0m | 15.1m | 12.1m | 12.4m | 13.3m | 12.7m | 13.4m | 10.7m |
Gross profit | 28.6m | 32.2m | 29.1m | 28.3m | 29.6m | 22.6m | 23.2m | 23.0m | 23.1m | 15.1m | 14.2m |
Gross profit Margin, % | 67% | 66% | 63% | 67% | 66% | 65% | 65% | 63% | 64% | 53% | 57% |
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (21.3m) | (37.6m) | (51.9m) | (19.8m) | (43.6m) | (53.8m) | (22.0m) | (49.2m) | (56.9m) | (18.1m) | (44.2m) |
Depreciation and Amortization | 2.3m | 4.6m | 6.9m | 2.0m | 3.9m | 5.9m | 1.7m | 3.5m | 5.3m | 1.2m | 2.9m |
Inventories | (1.5m) | (2.2m) | (1.0m) | (784.0k) | 1.8m | 2.1m | 112.0k | (463.0k) | (768.0k) | 1.8m | 339.0k |
Accounts Payable | (4.5m) | (3.5m) | (3.4m) | 391.0k | 809.0k | (1.0m) | 5.4m | 1.7m | 886.0k | (1.4m) | (5.1m) |
| USD | FY, 2016 |
|---|---|
Revenue/Employee | 246.7k |
Financial Leverage | 3.2 x |
Endologix Cybersecurity Score
Endologix Environment, Social & Governance (ESG) Ratings
Endologix Online and Social Media Presence
805 Twitter followers
Endologix has 805 Twitter Followers. The number of followers has increased 6.6% month over month and increased 8.1% quarter over quarter
Endologix's Trends
Twitter Engagement Stats for @endologix
463
Tweets
989
Following
805
Followers
12
Tweets last 30 days
9.8
Avg. likes per Tweet
100%
Tweets with engagement
Endologix News and Updates
United States // Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference
Endologix Blogs
Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System Outside of United States
Endologix announces first commercial implant of ALTO Abdominal Stent Graft System & official start of U.S. commercial release
Endologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System
Endologix, Inc. Comments on Recent FDA Update on Type III Endoleaks with AFX® Endovascular AAA System
Endologix Announces Equity Financing of $52 Million and Debt Restructuring Addressing 2020 Maturities and Financial Covenants
Endologix Frequently Asked Questions
When was Endologix founded?
Endologix was founded in 1992.
Who are Endologix key executives?
Endologix's key executives are John Onopchenko, Cindy Pinto and Reyna Fernandez.
How many employees does Endologix have?
Endologix has 528 employees.
What is Endologix revenue?
Latest Endologix annual revenue is $143.4 m.
What is Endologix revenue per employee?
Latest Endologix revenue per employee is $271.5 k.
Who are Endologix competitors?
Competitors of Endologix include Micreos, Enanta Pharmaceuticals and Mcneil.
Where is Endologix headquarters?
Endologix headquarters is located at 2 Musick, Irvine.
Where are Endologix offices?
Endologix has offices in Irvine, Santa Rosa, Rosmalen, 's-Hertogenbosch and in 1 other location.
How many offices does Endologix have?
Endologix has 5 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies